10-43113654-T-C

Variant summary

Our verdict is Likely pathogenic.
+8 Likely Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 8 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_StrongO3_ModerateO6_SupportingO7_Supporting

The NM_020975.6(RET):c.1858T>C (p.Cys620Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene RET is a known oncogene (CancerMine: 12 TSG, 1727 oncogene, 174 driver citations). The gene RET is a cancer driver gene (CancerMine: 12 TSG, 1727 oncogene, 174 driver citations). The variant allele was found at a cumulative frequency of 0.00000137 (AC=2) in the gnomAD database across 1,461,120 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000003. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV005404972: Functional studies indicate this variant impacts protein function [PMID:9230192, 17102091]." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.C620Y: Pathogenic (ClinVar VariationId 13916, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.C620= (synonymous): Conflicting_classifications_of_pathogenicity (ClinVar VariationId 549782) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). The variant has been observed in cBioPortal in 2 samples across 2 studies and 2 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

RET
NM_020975.6 missense

Scores

10
8
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:16

Conservation

PhyloP100: 6.52

Publications

9 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020975.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_pathogenic. The variant received 8 points.

O1Established oncogenic variant
CGI exact DNA-change oncogenic — Strong (O1); O1 contributing sources (4.0 pts): CGI (Cancer Genome Interpreter)
O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000000, AC = 2 — absent/extremely rare (O3 moderate [+2])
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 6 pathogenic, 2 benign (OR vs. background: 13.0); Variant does not impact splicing — splice-hotspot path not applicable

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_020975.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

RET NM_020975.6
MANE Select
HGVSc / HGVSpc.1858T>Cp.Cys620Arg
Exon rankExon 10 of 20
missense
Prot: NP_066124.1UniProt: P07949-1
RET NM_001406743.1
HGVSc / HGVSpc.1858T>Cp.Cys620Arg
Exon rankExon 10 of 21
missense
Prot: NP_001393672.1UniProt: P07949-1
RET NM_001406744.1
HGVSc / HGVSpc.1858T>Cp.Cys620Arg
Exon rankExon 10 of 20
missense
Prot: NP_001393673.1

Ensembl Transcripts

RET ENST00000355710.8
TSL:5MANE Select
HGVSc / HGVSpc.1858T>Cp.Cys620Arg
Exon rankExon 10 of 20
missense
Prot: ENSP00000347942.3UniProt: P07949-1
RET ENST00000340058.6
TSL:1
HGVSc / HGVSpc.1858T>Cp.Cys620Arg
Exon rankExon 10 of 19
missense
Prot: ENSP00000344798.4UniProt: P07949-2
RET ENST00000713926.1
HGVSc / HGVSpc.1729T>Cp.Cys577Arg
Exon rankExon 10 of 19
missense
Prot: ENSP00000519223.1UniProt: A0AAQ5BH28

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
AF: 0.00000137
AC:2
Hom:0
AN:1461120
Cov:31
GnomAD4 genome
Cov:32
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000743
AC:3
Hom:0
AN:40384
Showing 4 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
Epi25
(Epilepsy)
0.00 041954 0.0000150 166886
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
5
-
-
not provided (5)
3
-
-
Multiple endocrine neoplasia type 2A (3)
3
-
-
Multiple endocrine neoplasia, type 2 (3)
2
-
-
Hirschsprung disease, susceptibility to, 1 (2)
1
-
-
Aganglionic megacolon (1)
1
-
-
Aganglionic megacolon;C4048306:Multiple endocrine neoplasia, type 2 (1)
1
-
-
Hereditary cancer-predisposing syndrome (1)

Computational Scores

AlphaGenome AVI
Pathogenic26
AlphaMissense
Pathogenic0.98
BayesDel_addAF
Pathogenic0.55D
BayesDel_noAF
Pathogenic0.55
CADD
Uncertain25
DANN
Uncertain1.0
DEOGEN2
Pathogenic0.95D
Eigen
Uncertain0.63
Eigen_PC
Uncertain0.56
FATHMM_MKL
Uncertain0.95D
GPN-Star LLR
N/A-7.5
GPN-Star score
N/A7.5
LIST_S2
Benign0.82T
M_CAP
Pathogenic0.87D
MetaRNN
Pathogenic0.99D
MetaSVM
Pathogenic1.1D
Mutation Taster
N/A0/100disease causing (ClinVar)
MutationAssessor
Uncertain2.7M
PhyloP100
Uncertain6.5
popEVE
Benign-3.5
PrimateAI
Uncertain0.63T
PROVEAN
Pathogenic-5.4D
REVEL
Pathogenic0.90
Sift
Uncertain0.0010D
Sift4G
Uncertain0.037D
Varity_R
N/A0.98
VESM-3B
Benign-12
Showing 27 of 27 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.